ArticleExperimental hematology & oncology2022

Targeting Bruton's tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study.

Wenxue Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.